Putnam Investments LLC Gilead Sciences, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 4,536 shares of GILD stock, worth $499,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,536

Previous 4,536 -0.0%

Holding current value

$499,322

Previous $339,000 8.26%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $261,082 - $284,845	-3,531 Reduced 43.77%	4,536 $339,000
Q1 2023 May 22, 2023	BUY	$77.31 - $88.08 $10,978 - $12,507	142 Added 1.79%	8,067 $669,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $42,626 - $61,197	-684 Reduced 7.95%	7,925 $680,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $9,347 - $10,677	-157 Reduced 1.79%	8,609 $531,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $18,297 - $20,608	-317 Reduced 3.49%	8,766 $542,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $11,989 - $15,024	-207 Reduced 2.23%	9,083 $540,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $4.17 Million - $4.74 Million	-64,332 Reduced 87.38%	9,290 $675,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $11.9 Million - $12.9 Million	-176,354 Reduced 70.55%	73,622 $5.14 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $15.3 Million - $16.7 Million	240,675 Added 2587.62%	249,976 $17.2 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $15,420 - $17,594	-257 Reduced 2.69%	9,301 $601,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $14.7 Million - $16.8 Million	-260,311 Reduced 96.46%	9,558 $557,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $15.8 Million - $19.9 Million	-254,619 Reduced 48.55%	269,869 $17.1 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $36.7 Million - $42.6 Million	-506,903 Reduced 49.15%	524,488 $40.4 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.38 Million - $4.32 Million	53,911 Added 5.52%	1,031,391 $77.1 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $138 Million - $152 Million	-2,236,811 Reduced 69.59%	977,480 $63.5 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.01 Million - $1.11 Million	16,120 Added 0.5%	3,214,291 $204 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $162,470 - $182,191	2,626 Added 0.08%	3,198,171 $216 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.14 Million - $2.39 Million	34,149 Added 1.08%	3,195,545 $208 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $23.5 Million - $30.7 Million	-388,961 Reduced 10.96%	3,161,396 $198 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $14 Million - $15.5 Million	-196,000 Reduced 5.23%	3,550,357 $274 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $14.2 Million - $16.6 Million	218,743 Added 6.2%	3,746,357 $265 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $8.02 Million - $9.78 Million	-110,081 Reduced 3.03%	3,527,614 $266 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $60.1 Million - $70.6 Million	-845,105 Reduced 18.85%	3,637,695 $261 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $323 Million - $383 Million	4,482,800	4,482,800 $363 Million

Others Institutions Holding GILD

# of Institutions

2,286

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Gilead Sciences, Inc. Transaction History